Trials / Conditions / Severe Alopecia Areata
Severe Alopecia Areata
5 registered clinical trials studyying Severe Alopecia Areata — 4 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | A Long-Term Study to Learn About The Study Medicine Called Ritlecitinib in Children With Severe Alopecia Areat NCT07029828 | Pfizer | Phase 3 |
| Recruiting | A Study to Learn About Litfulo Capsule in People With Severe Alopecia Areata in Routine Clinical Practice. NCT07152119 | Pfizer | — |
| Recruiting | A Study to Learn About Medicine Called Ritlecitinib in Children Aged Between 6 to 12 Years With Severe Alopeci NCT07029711 | Pfizer | Phase 3 |
| Not Yet Recruiting | Study to Evaluate Safety and Efficacy of SYHX1901 Tablets in Severe Alopecia Areata Patients NCT06562894 | CSPC Ouyi Pharmaceutical Co., Ltd. | Phase 2 |
| Completed | A Study to Learn About the Medicine Called Ritlecitinib in Adults With Severe Alopecia Areata in Real-world Se NCT07200128 | Pfizer | — |